Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery
NACompletedINTERVENTIONAL
Enrollment
145
Participants
Timeline
Start Date
June 30, 2016
Primary Completion Date
June 30, 2019
Study Completion Date
September 30, 2019
Conditions
Ovarian Cancer
Interventions
DEVICE
EV1000(FloTrac System 4.0)
Trial Locations (1)
700156
Tata Medical Centre, Kolkata
All Listed Sponsors
lead
Tata Medical Center
OTHER
NCT03519165 - Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery | Biotech Hunter | Biotech Hunter